HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Ryo Naito Selected Research
Ryo Naito Research Topics
Disease
32
Coronary Artery Disease (Coronary Atherosclerosis)
03/2024 - 01/2014
17
Cardiovascular Diseases (Cardiovascular Disease)
08/2022 - 01/2012
12
Heart Failure
01/2023 - 02/2012
9
Acute Coronary Syndrome
11/2017 - 01/2014
7
Myocardial Infarction
01/2018 - 09/2012
5
Sleep Apnea Syndromes (Sleep Apnea)
10/2023 - 08/2018
5
Chronic Renal Insufficiency
09/2017 - 07/2015
4
Disease Progression
06/2018 - 06/2012
3
Obstructive Sleep Apnea
10/2023 - 07/2011
3
Neoplasms (Cancer)
11/2022 - 01/2019
3
Hemorrhage
01/2022 - 08/2015
3
Left Ventricular Dysfunction
02/2021 - 01/2019
3
Inflammation (Inflammations)
01/2020 - 10/2015
3
Thrombosis (Thrombus)
11/2015 - 01/2012
2
Diabetes Mellitus
03/2024 - 12/2016
2
Apnea
02/2023 - 01/2023
2
Central Sleep Apnea (Central Sleep Apnea Syndrome)
02/2023 - 02/2013
2
Atrial Fibrillation
01/2022 - 01/2021
2
Atherosclerosis
01/2020 - 01/2015
2
Death (Near-Death Experience)
11/2017 - 04/2016
2
Stroke (Strokes)
12/2016 - 01/2016
1
Allergic Rhinitis
10/2023
1
Rhinorrhea
10/2023
1
Nasal Obstruction
10/2023
1
Sleepiness
10/2023
1
Seasonal Allergic Rhinitis (Hay Fever)
10/2023
1
Sneezing
10/2023
1
Hyperuricemia
10/2023
1
Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
08/2022
1
Chronic Kidney Failure (Chronic Renal Failure)
01/2022
1
Hypoglycemia (Reactive Hypoglycemia)
01/2022
1
Type 2 Diabetes Mellitus (MODY)
09/2021
1
Body Weight (Weight, Body)
10/2020
1
Hyperthyroidism
06/2018
1
Malnutrition (Nutritional Deficiencies)
11/2017
1
Renal Insufficiency (Renal Failure)
09/2016
1
Coronary Disease (Coronary Heart Disease)
09/2016
1
Hypercholesterolemia
01/2016
Drug/Important Bio-Agent (IBA)
13
omega-Chloroacetophenone (Mace)
IBA
01/2018 - 01/2012
6
C-Reactive Protein
IBA
01/2019 - 07/2015
5
Lipoprotein(a)
IBA
08/2022 - 02/2016
5
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
01/2022 - 10/2015
3
LDL Cholesterol
IBA
02/2023 - 01/2014
3
Albumins
IBA
02/2023 - 08/2017
3
Cholesterol
IBA
02/2023 - 11/2017
3
Lipids
IBA
08/2022 - 01/2015
3
Indicators and Reagents (Reagents)
IBA
10/2020 - 09/2009
3
Serum Albumin
IBA
11/2017 - 08/2017
3
oxidized low density lipoprotein
IBA
12/2016 - 10/2015
2
Uric Acid (Urate)
IBA
10/2023 - 10/2023
2
Xanthine Dehydrogenase
IBA
10/2023 - 10/2023
2
Hemoglobins (Hemoglobin)
IBA
02/2023 - 10/2020
2
Brain Natriuretic Peptide (Natrecor)
FDA Link
02/2023 - 06/2018
2
Triglycerides (Triacylglycerol)
IBA
02/2023 - 10/2020
2
astaxanthine (astaxanthin)
IBA
02/2021 - 06/2020
2
LDL Receptors (LDL Receptor)
IBA
01/2020 - 01/2016
2
2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))
IBA
12/2016 - 08/2015
2
HDL Cholesterol
IBA
10/2015 - 01/2014
2
Glucose (Dextrose)
FDA Link
Generic
03/2015 - 02/2014
2
Anti-Bacterial Agents (Antibiotics)
IBA
08/2014 - 08/2010
1
Xanthine
IBA
10/2023
1
Hypoxanthine
IBA
10/2023
1
Anti-Allergic Agents (Antiallergic Agents)
IBA
10/2023
1
Creatinine
IBA
02/2023
1
Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)
IBA
02/2023
1
Apolipoprotein A-I (Apolipoprotein A1)
IBA
11/2022
1
Apolipoproteins
IBA
08/2022
1
Lipoproteins (Lipoprotein)
IBA
08/2022
1
Insulin (Novolin)
FDA Link
01/2022
1
Hypoglycemic Agents (Hypoglycemics)
IBA
01/2022
1
Rivaroxaban
IBA
01/2022
1
Biomarkers (Surrogate Marker)
IBA
10/2021
1
Sodium-Glucose Transporter 2 Inhibitors
IBA
09/2021
1
Canagliflozin
IBA
09/2021
1
Sodium-Glucose Transport Proteins
IBA
09/2021
1
ertugliflozin
IBA
09/2021
1
empagliflozin
IBA
09/2021
1
dapagliflozin
IBA
09/2021
1
Carbon Dioxide
IBA
06/2021
1
Sodium
IBA
10/2020
1
Peroxisome Proliferator-Activated Receptors (PPAR)
IBA
01/2020
1
Cytoplasmic and Nuclear Receptors (Nuclear Receptors)
IBA
01/2020
1
(R)-2-(3-((benzoxazol-2-yl-d4 (3- (4- methoxyphenoxy- d7)propyl)amino)methyl)phenoxy) butanoic acid
IBA
01/2020
1
Diuretics
IBA
06/2018
1
Warfarin (Coumadin)
FDA Link
Generic
12/2016
1
Metals
IBA
09/2016
1
Everolimus
FDA Link
10/2015
Therapy/Procedure
28
Percutaneous Coronary Intervention
03/2024 - 09/2012
12
Therapeutics
10/2023 - 08/2010
7
Stents
09/2016 - 01/2012
5
Drug-Eluting Stents
12/2016 - 01/2012
4
Continuous Positive Airway Pressure
10/2023 - 07/2011
3
Coronary Artery Bypass (Coronary Artery Bypass Surgery)
08/2017 - 03/2015
2
Patient Readmission
06/2022 - 09/2012
2
Catheter Ablation
01/2021 - 08/2014
1
Aftercare (After-Treatment)
10/2023
1
Renal Dialysis (Hemodialysis)
01/2022
1
Drug Therapy (Chemotherapy)
09/2021
1
Dual Anti-Platelet Therapy
12/2016
1
Secondary Prevention
01/2016